Home
News
Create
Screeners
Insights
Phaarmasia
33.
60
-0.40
(-1.18%)
Market Cap
₹23.00 Cr
PE Ratio
-14.36
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.18%
1M
-0.56%
6M
+11.26%
1Y
-32.80%
5Y
+15.86%
View Company Insights
Latest news about Phaarmasia
Phaarmasia Limited Board Approves Sale of Hyderabad Property Following Shareholder Consent
Oct 13, 2025
Phaarmasia Limited's Board of Directors has approved the sale of land and building in Hyderabad's IDA Jeedimetla area following shareholder approval via postal ballot. The resolution passed with 99.23% votes in favor. The board authorized specific executives to execute the sale agreement and register the sale deed. This decision could significantly impact the company's financial structure and future operations in the pharmaceutical sector.
Phaarmasia Limited Seeks Shareholder Approval for ₹25 Crore Property Sale
Sep 13, 2025
Phaarmasia Limited Reports Q1 FY2026 Results: Revenue Up 26.6% QoQ, Net Profit Rebounds
Aug 13, 2025
Phaarmasia Limited Reports Q1 FY2026 Results: Revenue Declines 17.1% YoY, Shows Sequential Improvement
Aug 11, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation